| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e0f7268aed9a3a71da2f8dc65a23b55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09ca9729ffc31d7114ca1ad545db552d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3a0d6297082cc4413878148c761e49b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-15 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate |
2014-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09e55b0403bbaabda40a700c549693b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd81c95fa8f8582fa9a91f16714c3a91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165e99d7a9895c31c3a823d01b98e290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b676c9d8d545a683f8e5b3f7fe46f27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf5f0651acb4224133033c101db3edf |
| publicationDate |
2014-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014181314-A1 |
| titleOfInvention |
Placental like alkaline phosphatase (plap) promoter mediated cell targeting |
| abstract |
The present invention relates to cell specific therapeutic modality by using a region of the PLAP Promoter. The invention further relates to specific expression of therapeutically PLAP useful sequences for specific transcriptional activation of this gene. The invention also relates to the PLAP region which may be used alone or in combination with other regions like enhancer sequences that augment cell or tumour specific gene expression. |
| priorityDate |
2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |